NCT01644435View on ClinicalTrials.gov

A Pilot Study to Determine Safety & Efficacy of Autologous Human Platelet Lysate (HPL) in Treatment of Acne Scarring

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

May 31, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

October 31, 2012

Conditions

ACNE SCARRING

Interventions

BIOLOGICAL

Autologous Human Platelet Lysate

Subjects will receive a single injection of Autologous Human Platelet Lysate for acne scarring

BIOLOGICAL

Autologous Human Platelet Lysate

Subjects will receive two injections of Autologous Human Platelet Lysate at an interval of one month for acne scarring

Trial Locations (1)

400610

Kasiak Research Pvt Ltd, Thāne

All Listed Sponsors

lead

Kasiak Research Pvt. Ltd.

INDUSTRY

NCT01644435 - A Pilot Study to Determine Safety & Efficacy of Autologous Human Platelet Lysate (HPL) in Treatment of Acne Scarring | Biotech Hunter | Biotech Hunter